In STREAM stage 2, this study compared two bedaquiline-containing regimens with the 9-month STREAM stage 1 regimen. Both bedaquiline-containing regimens, a 9-month oral regimen and a 6-month regimen with 8 weeks of second-line injectable, had superior efficacy compared with a 9-month injectable-containing regimen, with fewer cases of hearing loss.
Published: November 8, 2022
Sign up to receive our monthly Research Roundup email, which offers a selection of new public health research from major journals.
Policy Brief: Reducing Childhood Lead Poisoning in Indonesia
A content analysis of e-cigarette marketing on social media: Findings from the Tobacco…
Vital Strategies – RESET Alcohol Program
“Love with Less Salt”: evaluation of a sodium reduction mass media campaign in…
Vital Strategies – Cancer Registries Program
Report on Legal Framework Assessment on Civil Registration, Vital Statistics and Identification Management…
Integrated Use of Low-Cost Sensors to Strengthen Air Quality Management
Prioritizing Children: Environmental Health Indicators for China
Racial Disparities in United States Overdose Rates
Overdose Prevention Centers